Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1998 2
2001 1
2003 1
2004 3
2005 2
2006 4
2007 2
2008 5
2009 7
2010 11
2011 22
2012 23
2013 15
2014 30
2015 23
2016 17
2017 18
2018 13
2019 15
2020 19
2021 17
2022 9
2023 17
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

252 results

Results by year

Filters applied: . Clear all
Page 1
Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia.
Carson JL, Brooks MM, Hébert PC, Goodman SG, Bertolet M, Glynn SA, Chaitman BR, Simon T, Lopes RD, Goldsweig AM, DeFilippis AP, Abbott JD, Potter BJ, Carrier FM, Rao SV, Cooper HA, Ghafghazi S, Fergusson DA, Kostis WJ, Noveck H, Kim S, Tessalee M, Ducrocq G, de Barros E Silva PGM, Triulzi DJ, Alsweiler C, Menegus MA, Neary JD, Uhl L, Strom JB, Fordyce CB, Ferrari E, Silvain J, Wood FO, Daneault B, Polonsky TS, Senaratne M, Puymirat E, Bouleti C, Lattuca B, White HD, Kelsey SF, Steg PG, Alexander JH; MINT Investigators. Carson JL, et al. Among authors: silvain j. N Engl J Med. 2023 Dec 28;389(26):2446-2456. doi: 10.1056/NEJMoa2307983. Epub 2023 Nov 11. N Engl J Med. 2023. PMID: 37952133 Clinical Trial.
Effect of a Restrictive vs Liberal Blood Transfusion Strategy on Major Cardiovascular Events Among Patients With Acute Myocardial Infarction and Anemia: The REALITY Randomized Clinical Trial.
Ducrocq G, Gonzalez-Juanatey JR, Puymirat E, Lemesle G, Cachanado M, Durand-Zaleski I, Arnaiz JA, Martínez-Sellés M, Silvain J, Ariza-Solé A, Ferrari E, Calvo G, Danchin N, Avendaño-Solá C, Frenkiel J, Rousseau A, Vicaut E, Simon T, Steg PG; REALITY Investigators. Ducrocq G, et al. Among authors: silvain j. JAMA. 2021 Feb 9;325(6):552-560. doi: 10.1001/jama.2021.0135. JAMA. 2021. PMID: 33560322 Free PMC article. Clinical Trial.
Pharmacogenetics of clopidogrel.
O'Connor SA, Hulot JS, Silvain J, Cayla G, Montalescot G, Collet JP. O'Connor SA, et al. Among authors: silvain j. Curr Pharm Des. 2012;18(33):5309-27. doi: 10.2174/138161212803251880. Curr Pharm Des. 2012. PMID: 22724417 Review.
Biodegradable-Polymer or Durable-Polymer Stents in Patients at High Bleeding Risk: A Randomized, Open-Label Clinical Trial.
Valgimigli M, Wlodarczak A, Tölg R, Merkely B, Kelbæk H, Legutko J, Galli S, Godin M, Toth GG, Lhermusier T, Honton B, Dietrich PL, Stammen F, Ferdinande B, Silvain J, Capodanno D, Cayla G; Bioflow-DAPT Investigators. Valgimigli M, et al. Among authors: silvain j. Circulation. 2023 Sep 26;148(13):989-999. doi: 10.1161/CIRCULATIONAHA.123.065448. Epub 2023 Aug 25. Circulation. 2023. PMID: 37624364 Free PMC article. Clinical Trial.
Cangrelor: Fixing Life or Just a Leak?
Kerneis M, Silvain J, Montalescot G; ACTION Study Group. Kerneis M, et al. Among authors: silvain j. JACC Cardiovasc Interv. 2016 Sep 26;9(18):1914-6. doi: 10.1016/j.jcin.2016.07.025. JACC Cardiovasc Interv. 2016. PMID: 27659567 Free article. No abstract available.
Ticagrelor vs Clopidogrel for Complex Percutaneous Coronary Intervention in Chronic Coronary Syndrome.
Lattuca B, Mazeau C, Cayla G, Ducrocq G, Guedeney P, Laredo M, Dumaine R, El Kasty M, Kala P, Nejjari M, Hlinomaz O, Morel O, Varenne O, Leclercq F, Payot L, Spaulding C, Beygui F, Rangé G, Motovska Z, Portal JJ, Vicaut E, Collet JP, Montalescot G, Silvain J; ALPHEUS Investigators. Lattuca B, et al. Among authors: silvain j. JACC Cardiovasc Interv. 2024 Feb 12;17(3):359-370. doi: 10.1016/j.jcin.2023.12.011. JACC Cardiovasc Interv. 2024. PMID: 38355265 Clinical Trial.
Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction.
Puymirat E, Cayla G, Simon T, Steg PG, Montalescot G, Durand-Zaleski I, le Bras A, Gallet R, Khalife K, Morelle JF, Motreff P, Lemesle G, Dillinger JG, Lhermusier T, Silvain J, Roule V, Labèque JN, Rangé G, Ducrocq G, Cottin Y, Blanchard D, Charles Nelson A, De Bruyne B, Chatellier G, Danchin N; FLOWER-MI Study Investigators. Puymirat E, et al. Among authors: silvain j. N Engl J Med. 2021 Jul 22;385(4):297-308. doi: 10.1056/NEJMoa2104650. Epub 2021 May 16. N Engl J Med. 2021. PMID: 33999545 Clinical Trial.
Anticoagulation in Acute Coronary Syndrome-State of the Art.
Zeitouni M, Kerneis M, Nafee T, Collet JP, Silvain J, Montalescot G. Zeitouni M, et al. Among authors: silvain j. Prog Cardiovasc Dis. 2018 Jan-Feb;60(4-5):508-513. doi: 10.1016/j.pcad.2018.01.004. Epub 2018 Jan 13. Prog Cardiovasc Dis. 2018. PMID: 29339166 Review.
Impact of the antiplatelet strategy following patent foramen ovale percutaneous closure.
Guedeney P, Farjat-Pasos JI, Asslo G, Roule V, Beygui F, Hermida A, Gabrion P, Leborgne L, Houde C, Huang F, Lattuca B, Leclercq F, Mesnier J, Abtan J, Rouanet S, Hammoudi N, Collet JP, Zeitouni M, Silvain J, Montalescot G, Rodés-Cabau J; AIR-FORCE Task Force. Guedeney P, et al. Among authors: silvain j. Eur Heart J Cardiovasc Pharmacother. 2023 Nov 2;9(7):601-607. doi: 10.1093/ehjcvp/pvad023. Eur Heart J Cardiovasc Pharmacother. 2023. PMID: 36963773
252 results